Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Kanellis

Showing results (1-10 of 121) with videos related to

Pageof 13
Sort By:
Nephrology (Carlton, Vic.)|July 2, 2010
The CARI guidelines. Justification for living donor kidney transplantationJohn Kanellis,
Nephrology (Carlton, Vic.)|July 2, 2010
The CARI guidelines. Donors at risk: proteinuriaNeil Boudville, John Kanellis,
Nephrology (Carlton, Vic.)|July 2, 2010
The CARI guidelines. Donors at risk: haematuriaFrank Ierino, John Kanellis,
Nephrology (Carlton, Vic.)|May 14, 2019
KHA-CARI commentary on the KDIGO clinical practice guideline on the evaluation and care of living kidney donorsNeil Boudville, John Kanellis
Stroke|July 5, 2003
Editorial comment--Elevated uric acid and ischemic stroke: accumulating evidence that it is injurious and not neuroprotectiveJohn Kanellis, Richard J Johnson
Seminars in Nephrology|May 10, 2005
Thin basement membrane nephropathy and renal transplantationFrancesco L Ierino, John Kanellis
Nephrology (Carlton, Vic.)|January 29, 2011
Understanding crossmatch testing in organ transplantation: A case-based guide for the general nephrologistWilliam R Mulley, John Kanellis
Seminars in Nephrology|January 22, 2005
Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular diseaseJohn Kanellis, Duk-Hee Kang
The Medical Journal of Australia|September 14, 2018
Kidney donation and transplantation in Australia: more than a supply and demand equationJeremy R Chapman, John Kanellis
Nephrology (Carlton, Vic.)|January 29, 2011
Slow and steady. Reducing thrombotic events in renal transplant recipients treated with IVIg for antibody-mediated rejectionLouis Huang, John Kanellis, William Mulley
Pageof 13

Showing results (1-10 of 121) with videos related to

Sort By:
Pageof 13
Nephrology (Carlton, Vic.)|July 2, 2010
The CARI guidelines. Justification for living donor kidney transplantationJohn Kanellis,
Nephrology (Carlton, Vic.)|July 2, 2010
The CARI guidelines. Donors at risk: proteinuriaNeil Boudville, John Kanellis,
Nephrology (Carlton, Vic.)|July 2, 2010
The CARI guidelines. Donors at risk: haematuriaFrank Ierino, John Kanellis,
Nephrology (Carlton, Vic.)|May 14, 2019
KHA-CARI commentary on the KDIGO clinical practice guideline on the evaluation and care of living kidney donorsNeil Boudville, John Kanellis
Stroke|July 5, 2003
Editorial comment--Elevated uric acid and ischemic stroke: accumulating evidence that it is injurious and not neuroprotectiveJohn Kanellis, Richard J Johnson
Seminars in Nephrology|May 10, 2005
Thin basement membrane nephropathy and renal transplantationFrancesco L Ierino, John Kanellis
Nephrology (Carlton, Vic.)|January 29, 2011
Understanding crossmatch testing in organ transplantation: A case-based guide for the general nephrologistWilliam R Mulley, John Kanellis
Seminars in Nephrology|January 22, 2005
Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular diseaseJohn Kanellis, Duk-Hee Kang
The Medical Journal of Australia|September 14, 2018
Kidney donation and transplantation in Australia: more than a supply and demand equationJeremy R Chapman, John Kanellis
Nephrology (Carlton, Vic.)|January 29, 2011
Slow and steady. Reducing thrombotic events in renal transplant recipients treated with IVIg for antibody-mediated rejectionLouis Huang, John Kanellis, William Mulley
Pageof 13